Form 13-F position report

NKGEN BIOTECH INC

Reported by Alberta Investment Management Corp

NKGNW CUSIP 65488A119 Manager CIK 0001463559

Reported 40,000 shares, unchanged from the prior quarter.

Reported value -45.6%; share count 0.0% vs. the prior quarter.

Unchanged
% of reported 13F value < 0.01% This manager · Q2 2024
Shares 40,000 Quarter-end amount reported
Reported value $3,480 Fair value at quarter end
Consecutive quarters held 3 Through Q2 2024

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2023-12-31 3232
2024-03-31 6400
2024-06-30 3480
2024-09-30 2828
2024-12-31 4000
2025-03-31 0

Quarterly position history

How this manager's reported quarter-end position changed over time.

6 quarters
Quarterly reported position history for NKGEN BIOTECH INC held by Alberta Investment Management Corp.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q1 2025 Reduced 0 -40,000 (-100.0%) 0 $0 2025-05-08
Q4 2024 Unchanged 40,000 0 (0.0%) < 0.01% $4,000 2025-02-03
Q3 2024 Unchanged 40,000 0 (0.0%) < 0.01% $2,828 2024-11-05
Q2 2024 Unchanged 40,000 0 (0.0%) < 0.01% $3,480 2024-08-13
Q1 2024 Unchanged 40,000 0 (0.0%) < 0.01% $6,400 2024-05-15
Q4 2023 New 40,000 +40,000 (0.0%) < 0.01% $3,232 2024-02-12

Who else reported the position

33 managers reported NKGEN BIOTECH INC for Q2 2024.

Managers reporting NKGEN BIOTECH INC in Q2 2024.
Manager Activity Shares Change % of reported 13F Reported value Tenure
Atalaya Capital Management LP Unchanged 30,000 0 < 0.01% $3,600,000 3 qtrs
RIVERNORTH CAPITAL MANAGEMENT LLC Unchanged 652,432 0 < 0.01% $65,243 3 qtrs
BNP PARIBAS FINANCIAL MARKETS Unchanged 150,000 0 < 0.01% $14,805 2 qtrs
ADAGE CAPITAL PARTNERS GP L L C Reduced 161,325 -20,475 < 0.01% $14,035 3 qtrs
Balyasny Asset Management LLC Unchanged 139,893 0 < 0.01% $13,849 3 qtrs
Exos Asset Management LLC Unchanged 146,254 0 0.02% $13,326 2 qtrs
Shaolin Capital Management LLC Unchanged 128,274 0 < 0.01% $11,160 3 qtrs
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND Unchanged 100,000 0 < 0.01% $9,900 3 qtrs
KIM LLC Unchanged 92,040 0 < 0.01% $9,112 3 qtrs
JANE STREET GROUP LLC Unchanged 100,165 0 < 0.01% $8,714 3 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
June 30, 2024
Filed
August 13, 2024
Filing type
13F-HR
Position type
*W EXP 05/31/202

Voting authority reported

Sole
40,000
Shared
0
None
0

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.